Holen Sie sich die Stockscreener-App
33.46
1.33%
0.44
Handel nachbörslich:
33.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ENOV?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$33.02
Offen:
$33.17
24-Stunden-Volumen:
1.07M
Relative Volume:
1.00
Marktkapitalisierung:
$1.92B
Einnahmen:
$2.15B
Nettoeinkommen (Verlust:
$-809.46M
KGV:
-2.3986
EPS:
-13.95
Netto-Cashflow:
$-38.98M
1W Leistung:
+4.14%
1M Leistung:
+12.85%
6M Leistung:
-24.47%
1J Leistung:
-25.16%
1-Tages-Spanne:
$32.65
$33.60
1-Wochen-Bereich:
$30.84
$33.95
52-Wochen-Spanne:
$28.83
$49.83
Enovis Corp Stock (ENOV) Company Profile
Firmenname
Enovis Corp
Sektor
Branche
Telefon
(302) 252-9160
Adresse
2711 CENTERVILLE ROAD, WILMINGTON
Vergleichen Sie ENOV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
33.46 | 1.92B | 2.15B | -809.46M | -38.98M | -13.95 |
|
ABT
Abbott Laboratories
|
134.11 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
103.63 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
391.81 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.28 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.02 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-10-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-06-13 | Eingeleitet | JP Morgan | Neutral |
| 2024-02-13 | Eingeleitet | Stephens | Overweight |
| 2024-01-22 | Eingeleitet | UBS | Buy |
| 2024-01-03 | Eingeleitet | William Blair | Outperform |
| 2023-12-15 | Bestätigt | Needham | Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-26 | Eingeleitet | Needham | Buy |
| 2023-05-12 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-10-11 | Eingeleitet | Goldman | Buy |
| 2022-09-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-09-12 | Eingeleitet | Evercore ISI | Outperform |
| 2022-06-28 | Eingeleitet | Argus | Hold |
| 2022-06-27 | Fortgesetzt | Loop Capital | Buy |
| 2022-06-16 | Eingeleitet | Wells Fargo | Equal Weight |
Alle ansehen
Enovis Corp Aktie (ENOV) Neueste Nachrichten
Enovis Corporation Performance Slips Against NYSE Composite - Kalkine Media
Enovis (NYSE:ENOV shareholders incur further losses as stock declines 3.0% this week, taking five-year losses to 34% - simplywall.st
Transcript : Enovis Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 02 - MarketScreener
Enovis to Present at Upcoming Investor Conferences in June - MSN
Enovis Corporation Q1 2025 Earnings Preview - MSN
Enovis to Participate in Upcoming Investor Conferences - The Manila Times
Enovis to Participate in Upcoming Investor Conferences | ENOV St - GuruFocus
Enovis Corporation Management to Participate in Upcoming Investor Conferences - Nasdaq
Enovis Corp (ENOV) Stock Price Down 3.51% on Jun 2 - GuruFocus
Optimistic Buy Rating for Enovis: Strong Growth, Margin Expansion, and Attractive Valuation - TipRanks
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know - Yahoo
Orthopedic Braces & Supports Market Focused Insights - GlobeNewswire
Orthopedic Braces & Supports Market Focused Insights 2025-2030, with Key Vendor Profiles for BREG, Bauerfeind, DeRoyals, Enovis, Ottobock, Ossur and Tynor - Yahoo Finance
Enovis Corp (ENOV) Trading Down 3.12% on May 21 - GuruFocus
Enovis holds annual meeting, stockholders vote on proposals By Investing.com - Investing.com India
Enovis holds annual meeting, stockholders vote on proposals - Investing.com
Enovis Holds Annual Meeting, Elects Board Directors - TipRanks
Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Enovis (NYSE:ENOV) - Yahoo Finance
Canaccord cuts Enovis stock target to $70, maintains Buy rating By Investing.com - Investing.com South Africa
Canaccord cuts Enovis stock target to $70, maintains Buy rating - Investing.com Australia
Enovis (ENOV): Canaccord Genuity Lowers Price Target to $70 | EN - GuruFocus
Canaccord Adjusts Price Target for Enovis (ENOV) Following Q1 Re - GuruFocus
Enovis price target lowered to $70 from $75 at Canaccord - TipRanks
Enovis Corporation (NYSE:ENOV) Q1 2025 Earnings Call Transcript - Insider Monkey
Analysts Conflicted on These Industrial Goods Names: Carrier Global (CARR), BrightView Holdings (BV) and Enovis (ENOV) - The Globe and Mail
Enovis Corporation’s Strong Q1 2025 Earnings Call - TipRanks
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know - MSN
UBS Adjusts Price Target on Enovis to $65 From $75, Maintains Buy Rating - marketscreener.com
JMP Securities Cuts Enovis (NYSE:ENOV) Price Target to $55.00 - Defense World
Enovis (ENOV) Q1 Earnings and Revenues Surpass Estimates - MSN
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook - MSN
Analysts Offer Insights on Industrial Goods Companies: Enovis (ENOV), Boeing (BA) and Arlo Technologies (ARLO) - The Globe and Mail
Enovis’ first-quarter net sales grow 8% to USD 559 million - Medical Buyer
Enovis stock price target cut to $55 by JMP Securities - Investing.com South Africa
Where Enovis Stands With Analysts - Benzinga
JMP Securities Adjusts Target Price for Enovis (ENOV) | ENOV Sto - GuruFocus
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Sto - GuruFocus
Is Enovis (NYSE:ENOV) A Risky Investment? - simplywall.st
Enovis (ENOV) Price Target Lowered by Needham Analyst | ENOV Stock News - GuruFocus
Enovis (ENOV) Price Target Reduced by Citizens JMP Amid Positive Outlook | ENOV Stock News - GuruFocus
Enovis: Q1 Earnings Snapshot - New Haven Register
Enovis Q1 2025 slides: revenue beats expectations, profit guidance lowered on tariffs - Investing.com
Enovis Corp (ENOV) Q1 2025 Earnings Call Highlights: Strong Reve - GuruFocus
Finanzdaten der Enovis Corp-Aktie (ENOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.54%
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):